IntelGenx Partners with Gensco® Pharma to Market RIZAPORT® in the United States
12 déc. 2018 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Dec. 12, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive...
IntelGenx Engages Focus Communications for Investor Relations Program
30 nov. 2018 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce the engagement of Focus Communications...
IntelGenx Begins Montelukast VersaFilm™ Dosing in Patients with Mild to Moderate Alzheimer’s Disease in Phase 2a Study
27 nov. 2018 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that patient dosing has commenced in the Phase 2a...
IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT®
20 nov. 2018 08h00 HE
|
IntelGenx Technologies Corp.
- PDUFA Goal Date of April 1, 2019 - SAINT LAURENT, Quebec, Nov. 20, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that its...
IntelGenx Closes Private Placement Financing
13 nov. 2018 16h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of Tilray, Inc.’s strategic...
IntelGenx Reports Third Quarter 2018 Financial Results
08 nov. 2018 16h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today reported financial results for the third quarter...
IntelGenx Announces Definitive Agreement with Tilray® to Form an Exclusive, Worldwide Partnership for Cannabis-Infused VersaFilm™ Products
07 nov. 2018 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive...
IntelGenx to Report Third Quarter 2018 Financial Results on November 8, 2018 – Conference Call to Follow
01 nov. 2018 16h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 01, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its third quarter 2018 financial results...
The Spanish Agency of Medicines and Medical Devices Grants Marketing Authorization of RIZAPORT®
31 oct. 2018 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 31, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announced that its commercialization partner for...
IntelGenx Announces Exercise of Over-Allotment Option
26 oct. 2018 16h02 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces that in connection with its previously...